What is 17alpha Hydroxyprogesterone Caproate?

Hydroxyprogesterone caproate
is a progestogen structurally related to progesterone that has been used
for recurrent miscarriage and various menstrual disorders. In recurrent
miscarriage associated with proven progesterone deficiency, suggested
doses have been 250 to 500 mg weekly by intramuscular injection during
the first half of pregnancy.

The Safety of 17alpha Hydroxyprogesterone Caproate Use in Pregnancy

The evidence for the safety of the use of 17alpha Hydroxyprogesterone
Caproate, (17OHP-C), in pregnancy is well documented by animal and clinical
studies. Reviews of this topic by knowledgeable authors have uniformly
concluded that no evidence exists that administration of 17OHP-C in pregnancy
represents a significant risk to mother, fetus or newborn.

Hydroxyprogesterone Links

  • MFMU Maternal Fetal Medicine Units Network
  • March of Dimes March of Dimes
  • White Paper Critical Issues
    in Quality Compounding
  • Wedgewood Pharmacy Compounders
    of 17P Hydroxyprogesterone
  • ACOG American College of Obstetricians
    and Gynecologists
  • ORGYN The Essential Resource in
    Obstetrics and Gynecology
  • OBGYNLINX Part of the MDLinx
  • ACOG News Release Progesterone
    Recommended In Certain High Risk Pregnancies to Help Prevent Preterm

Contact us today for more information about Hydroxyprogesterone